Harrow Health Inc
NASDAQ:HROW

Watchlist Manager
Harrow Health Inc Logo
Harrow Health Inc
NASDAQ:HROW
Watchlist
Price: 26.43 USD 0.38%
Market Cap: 969.7m USD

Intrinsic Value

The intrinsic value of one HROW stock under the Base Case scenario is 90.08 USD. Compared to the current market price of 26.43 USD, Harrow Health Inc is Undervalued by 71%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HROW Intrinsic Value
90.08 USD
Undervaluation 71%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Harrow Health Inc

Valuation History Unavailable

Historical valuation for HROW cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Harrow Health Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Harrow Health Inc

Current Assets 169.5m
Cash & Short-Term Investments 66.7m
Receivables 77.3m
Other Current Assets 25.5m
Non-Current Assets 194.6m
PP&E 11.9m
Intangibles 182.7m
Efficiency

Free Cash Flow Analysis
Harrow Health Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Harrow Health Inc

Revenue
212.9m USD
Cost of Revenue
-54.2m USD
Gross Profit
158.6m USD
Operating Expenses
-154.1m USD
Operating Income
4.5m USD
Other Expenses
-26.2m USD
Net Income
-21.7m USD
Fundamental Scores

HROW Profitability Score
Profitability Due Diligence

Harrow Health Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
ROE is Increasing
42/100
Profitability
Score

Harrow Health Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

HROW Solvency Score
Solvency Due Diligence

Harrow Health Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Positive Net Debt
Short-Term Solvency
Average D/E
32/100
Solvency
Score

Harrow Health Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HROW Price Targets Summary
Harrow Health Inc

Wall Street analysts forecast HROW stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HROW is 58.59 USD with a low forecast of 52.72 USD and a high forecast of 68.25 USD.

Lowest
Price Target
52.72 USD
99% Upside
Average
Price Target
58.59 USD
122% Upside
Highest
Price Target
68.25 USD
158% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Harrow Health Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for HROW is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

HROW Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one HROW stock?

The intrinsic value of one HROW stock under the Base Case scenario is 90.08 USD.

Is HROW stock undervalued or overvalued?

Compared to the current market price of 26.43 USD, Harrow Health Inc is Undervalued by 71%.

Back to Top